Skip to main content

Advertisement

SpringerLink
Log in

Radioimmunodiagnosis of pancreatic cancer disease

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

From a theoretical point of view, immunoscintigraphy of exocrine pancreatic cancer offers itself as a promising diagnostic method. However, the actually available clinical and experimental data point out that the indication for diagnostic application in patients with pancreatic carcinoma has to be viewed more critically than in the case of, e.g., colorectal cancer disease. The quality of imaging depends on a lot of factors, such as the cellular antigen expression, the affinity of the MAbs to the corresponding antigens expressed by the cells, tumor vascularization, tumor size, and unspecific background activity as well as on labeling techniques, the kind of antibodies used, and the technical equipment. All these factors may vary from one patient to the other and from one center to the other. In summarizing the available clinical data, we have to state that immunoscintigraphy does not allow early detection of pancreatic cancer and, consequently, does not allow screening for early stages in asymptomatic patients. Even nowadays primary diagnosis and staging should be based on the imaging methods of ultrasound, CT and/or ERCP, and angiography. With respect to detection of local recurrence and especially peritoneal carcinosis, immunoscintigraphy, however, may be superior when compared to the other imaging methods. The potential clinical value for followup and as a preinvestigation to assess the probability of effective MAb treatment has still to be evaluated in prospective clinical studies. Altogether, a lot of experimental and clinical work remains to be done to introduce immunoscintigraphy of pancreatic cancer into clinical practice as a routine method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrew SM, Pimm MV, Perkins AC, Baldwin RW. Comparative imaging and biodistribution studies with anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts. Eur. J. Nucl. Med. 1986; 12: 168–173.

    Article  PubMed  CAS  Google Scholar 

  2. Arps H, Dietel M, Klapdor R, Kremer B. Immunohistologically determined expression of the tumor-associated antigents CA19-9, CA 125, 17-1A and CA 50 in tumors of the gastro-intestinai tract. In: Clinical Relevance of New Monoclonal A.ntibodies, 3rd Symposium on Tumor Markers, Hamburg 1985. Greten H, Klapdor R, eds., Stuttgart-New York, Georg Thieme Verlag, 1986; pp. 276–284.

    Google Scholar 

  3. Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxydase assay. Cancer Res. 1982;42: 4820–4823.

    PubMed  CAS  Google Scholar 

  4. Baum RP, Lorenz M, Senekowitsch R, Albrecht M, Hör G. Klinische Ergebnisse der Immunszintigraphie und Radioimmuntherapie. Nucl. Med. 1987;26: 68–78.

    CAS  Google Scholar 

  5. Bertoglio F, Percivale P, Bartolomeo S, Schenone F, Meszaros P, Conzi GF, Spina B, Nicolo G, Spagnolo W, Badellino F. Radioimmunoguided surgery (RIGS-TM) for colorectal cancer with B72.3 125-I-monoclonal antibody. In: Recent Results in Tumor Diagnosis and Therapy, Klapdor R, ed., San Francisco, Zuckschwerdt, München Bern Wien, 1990; pp. 437–443.

    Google Scholar 

  6. Brockmann WP, Lehmann U, Klapdor R. Stellenwert der Sonographie bei der Verlaufskontrolle des Pankreaskarzinoms. CT-Sonographie 1982;2: 190.

    PubMed  CAS  Google Scholar 

  7. Chatal JF, Saccavini JC, Fumoleau P, Doulliard JC, Curtet CH, Kremer M, Le Mevel B, Koprowski H. Immunscintigraphy of colon carcinoma. J. Nuc. Med. 1984;25: 307–314.

    CAS  Google Scholar 

  8. Chatal J-F. Monoclonal Antibodies in Immunoscintigraphy. Boca Raton, FL, CRC Press, 1989; p. 423.

    Google Scholar 

  9. Del Villano BC, Brennan S, Brock P. Radioimmunometric assay for monoclonal antibody-defined tumor marker CA 19-9. Clin. Chem. 1983;29: 549–552.

    PubMed  Google Scholar 

  10. Delaloye B, Bischof-Delaloye A, Volant C. First approach to therapy of liver metastases in colorectal carcinoma by intrahepatically infused 131-J labelled monoclonal anti-CEA antibodies. Eur. J. Nucl. Med. 1985; 11: A37.

    Article  Google Scholar 

  11. Delaloye B, Bischof-Delaloye A, Buchegger F, von Fliedner V, Grob JP, Volant JC, Pettavel J, Mach JP. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123-I-labeled Fab or F(ab)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J. Clin. Invest. 1986; 77: 301–305.

    Article  PubMed  CAS  Google Scholar 

  12. Grabbe E, Hagemann J, Klapdor R, Pfeiffer M. Sonographie und Computertomographie in der Verlaufskontrolle des Pankreaskarzinoms. Fortschr. Geb. Roentgenstr. 1980; 133: 139.

    Google Scholar 

  13. Gudjonsson B. Cancer of the pancreas—50 years of surgery. Cancer. 1987;60: 2284–2303.

    CAS  Google Scholar 

  14. Guthoff A, Rothe B. Ultraschall (US) und Computertomographie (CT) nach Operationen am Pankreas. In: Der operierte Patient—Operationen am Pankreas unter besonderer Berücksichtigung des Karzinoms. Klapdor R, ed., Die Gastroenterologische Reihe, vol. 26; 1986: pp. 57–88.

  15. Hermanek P, Sobin LH eds. TNM Classification of Malignant Tumors. 4th ed. Geneva, International Union Against Cancer, 1987; p. 251. Radioimmunodiagnosis

  16. Horstmeier U, Klapdor R, Bahlo M, Montz R. Immunoscintigraphy with combinations of various monoclonal antibodies—studies on xenografts of human gastrointestinal carcinomas. Nucl. Med. 1988; 27: 46–50.

    CAS  Google Scholar 

  17. Ihse, I, Isaksson G. Pancreatic carcinoma: Diagnosis and treatment. Clin. Gastroenterol. 1984; 13: 961–984.

    PubMed  CAS  Google Scholar 

  18. Klapdor R, Lehmann U, Bahlo M, Greten H, van Ackeren H, Dallek M, Schreiber HW. CA 19-9 in der Diagnostik und Differential-diagnostik des exkretorischen Pankreaskarzinoms. Tumor Diagn. & Ther. 1983; 4: 197–201.

    Google Scholar 

  19. Klapdor R, Greten H. Das tumor-assoziierte Antigen CA 19-9 in der Differentialdiagnostik und Verlaufkontrolle von Malignomen des Pankreas und Magen-Darm-Traktes. Dtsch. med. Wschr. 1984; 109: 1935–1937.

    PubMed  CAS  Google Scholar 

  20. Klapdor R, Lehmann U, Greten H. Sonographie bei Lebermetastasen des Pankreaskarzinoms. Dtsch. med. Wschr. 1984; 109: 807.

    PubMed  CAS  Google Scholar 

  21. Klapdor R, Clinical course and follow-up of patients suffering from pancreatic carcinoma. In: New Tumor Associated Antigens, 2nd Symp. Tumor Markers, Hamburg 1984. Greten H, Klapdor R, eds., Stuttgart, Georg Thieme Verlag, 1985; pp. 2–10.

    Google Scholar 

  22. Klapdor R, Montz R, Greten H, Chatal JF, Douillard JY, Saccavini JC, Dietal M. Immunszintigraphie und Radioimmuntherapie des transplantierten Pankreaskarzinoms. Tierexperimentelle Untersuchungen mit 131-J-markierten monoklonalen Antikörpern gegen CA 19-9, CEA and CA 125. Nucl. Med. 1985; 24: 227–232.

    CAS  Google Scholar 

  23. Klapdor R, Bahlo M, Montz R, Dietel M, Kremer B, Dimigen J, Chatal JF, Douillard JY, Saccavini, JC. Immunoscintigraphy of gastrointestial carcinomas especially pancreatic cancer with 131-I-anti-CA 19-9, 131-I-anti-CEA and 131-I-anti-CA 125. Experimental studies on xenografts in nude mice. In: Clinical Relevance of New Monoclonal Antibodies, 3rd Symp Tumor Markers, 1985. Greten H, Klapdor R, eds., Stuttgart, Georg Thieme Verlag, 1986; pp. 362–375.

    Google Scholar 

  24. Kalpdor R, Montz R. Clinical and immunological response to the therapy of pancreatic cancer with murine monoclonal antibodies. In: Immunotherapy and Scintigraphy of Tumors with Monoclonal Antibodies. Epenetos AA, Oberhausen E, Reisfeld RA, eds., Zuckschwerdt, München. Aktuelle Onkoiogie 1988; 41: 87–100.

    Google Scholar 

  25. Klapdor R. Interaction of monoclonal antibodies with biological response modifiers and cytostatics. In: Cancer Therapy. Berger HG, ed., Berlin-Heidelberg, Springer Verlag, 1989; pp. 57–70.

    Google Scholar 

  26. Klapdor R. Zum Stand der Früherkennung des Pankreaskarzinoms. Internist 1989; 30: 752–758.

    PubMed  CAS  Google Scholar 

  27. Klapdor R, Montz R. Immunoscintigraphy of pancreatic cancer: relevance for diagnosis and therapy. In: Monoclonal Antibodies in Immunoscintigraphy. Chatal JF, ed., Boca Raton, FA, CRC Press, 1989; pp. 154–163.

    Google Scholar 

  28. Klapdor R, Montz R. Immunoscintigraphy of carcinomas of the gastrointestinal tract, mainly pancreatic and colorectal tumors, with 99mTc-labeled antibodies—comparative studies in patients and in nude mice bearing human xenografts. In preparation.

  29. Klapdor R, Bahlo M, Montz R. Induction of HAMA production by immunoscintigraphy and immunotherapy using mouse monoclonal antibodies. In: Recent Results in Tumor Diagnosis and Therapy. 5th Symposium on Tumor Markers, 1989. Klapdor R, ed., San Francisco, W. Zuckschwerdt München Bern Wien, 1990; pp. 464–468.

    Google Scholar 

  30. Lamerz R, Fateh-Moghadam A. Carcinofetale Antigene. II. Carcino-embryonales Antigen. Klin. Wschr. 1975; 53: 193–198.

    Article  PubMed  CAS  Google Scholar 

  31. Martin EW, Mojzisik CM, Hinkle GH, Sampsel J, Siddigi MA, Tuttle SE, Sickle-Santanello B, Colcher D. Thurston MO, Bel JG, Farrar WB, Schlom J. Radioimmunoguided surgery using monoclonal antibody. Am. J. Surg. 1988; 156: 386–392.

    Article  PubMed  Google Scholar 

  32. Montz R, Klapdor R, Kremer B, Rothe B. Immunszintigraphie und SPECT bei Patienten mit Pankreaskarzinom. Nucl. Med. 1985;24: 232–237.

    CAS  Google Scholar 

  33. Montz R, Klapdor R, Rothe B, Heller M. Immunoscintigraphy and radioimmunotherapy in patients with pancreatic carcinoma. Nucl. Ned. 1985;25: 239–244.

    Google Scholar 

  34. Montz R, Klapdor R, Rothe B, Greten Hs Schreiber HW, Schneider C. Immunoscintigraphy with 131-I-anti-CA 19-9 and 131-I-anti-CEA in cases of gastrointestinal carcinomas, especially of pancreatic carcinomas: a comparison between planar scintigraphy and SPECT. In: Clinical Relevance of New Monoclonal Antibodies, 3rd Symp. Tumor Markers, 1985. Greten H, Klapdor R., eds., Stuttgart, Georg Thieme Verlag, 1986; pp.384–392.

    Google Scholar 

  35. Montz R, Klapdor R, Rothe B. Immunoscintigraphy and SPECT in patients with gastrointestinal carcinomas: 111-Indium labeled monoclonal antibodies (MA) vs. 131-Iodine-MA. In: New Tumour Markers and Their Monoclonal Antibodies—Actual Clinical Relevance for Diagnosis and Therapy of Solid Tumours, 4th Symposium on Tumor Markers, 1986. Klapdor R, ed., Stuttgart, Georg Thieme Verlag, 1987; pp. 475–477.

    Google Scholar 

  36. Montz R, Klapdor R. Immunoscintigraphy in pancreas carcinoma. A model for critical evaluation of radiolabeled monoclonal antibodies using planar imaging and SPECT. In: Immunotherapy and Scintigraphy of Tumors with Monoclonal Antibodies. Epenetos AA, Oberhausen E, Reisfeld RA, eds., Munich, W. Zuckschwerdt Verlag, 1988; pp. 55–62.

    Google Scholar 

  37. Oehr P, Schultes B, Liu Q, Altreuther M, Bockisch A, Biersack HJ. Standardized phantom evaluation of hand-guided probes for detection of radioactivity during surgery. In: Recent Results in Tumor Diagnosis and Therapy. 5th Symposium on Tumor Markers, 1989. Klapdor R, ed., San Francisco, W. Zuckschwerdt, Miinchen Bern Wien, 1990; pp. 444–449.

    Google Scholar 

  38. Oehr P, Liu Q, Schultes B, Altreuther M, Biersack HJ. The effect of streptavidin on the distribution of 99mTc-Biotin in rats. In: Recent Results in Tumor Diagnosis and Therapy. 5th Symposium on Tumor Markers, 1989. Klapdor R. ed., San Francisco, W. Zuckschwerdt Verlag München Bern Wien, 1990, pp. 421–426.

    Google Scholar 

  39. Pimm MV, Perkins AC, Armitage NC, Baldwin RW. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localisation of radiolabeled monoclonal antibody in cancer patients. J. Nucl. Med. 1985; 26: 1011.

    CAS  Google Scholar 

  40. Reuter M, Montz R, de Heer K, Klapdor R, Schreiber HW. Intraoperative immunoscintimetry using 99mTc-Labeled antibodies. In: Recent Results in Tumor Diagnosis and Therapy. Klapdor R. ed., San Francisco, W. Zuckschwerdt München Bern Wien, 1990; pp. 429–436.

    Google Scholar 

  41. Saccavini JC. Radiolabeling of monoclonal antibodies—quality control. In: New Tumor Markers and Their Monoclonal Antibodies—Actual Clinical Relevance for Diagnosis and Therapy of Solid Tumors. 4th Symp. Tumor Markers, 1986. Greten H, Klapdor R, eds., Stuttgart, Georg Thieme Verlag, 1987; pp. 403–410.

    Google Scholar 

  42. Sardi A, Workman M, Mojzisik C, Hinkle G, Nieroda C, Martin EW. Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). Arch. Surg. 1989;124: pp. 55–59.

    PubMed  CAS  Google Scholar 

  43. Schein PS. The role of chemotherapy in the management of gastric and pancreatic carcinomas. Seminars in Oncology XII No. 4 Suppl. 1985;6: 49–60.

    Google Scholar 

  44. Schwarz A, Steinsträsser A. A novel approach to 99mTC-labeled monoclonal antibodies. J. Nucl. Med. 1987;28: 721.

    Google Scholar 

  45. Senekovitsch R, Baum RP, Maul FD, Möllenstädt S, Kriegel H, Hör G. Biokinetic studies of 131-i-labeled F(ab)2-fragments of monoclonal antibodies in nude mice xenografted with human ovarian or pancreatic carcinoma. In: Clinical Relevance of New Monoclonal Antibodies, 3rd Symp. Tumor Markers, 1985. Greten H, Klapdor R, eds., Stuttgart, Georg Thieme Verlag, 1986; pp. 419–425.

    Google Scholar 

  46. Sirinek KR, Aust JB. Pancreatic cancer: Continuing diagnostic and therapeutic dilemma. Sug. Clin. North. Amer. 1986;66: 757–777.

    CAS  Google Scholar 

  47. Tsuchiya R, Noda T, Harada N, Miyamoto T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, Eto T. Collective review of small carcinomas of the pancreas. Ann. Surg. 1986;203: 77–81.

    Article  PubMed  CAS  Google Scholar 

  48. Tuttle SE, Jewell SD, Mojzisik CM et al. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: Comparison of in vivo gamma probe counts with in vitro MAb radiolocalization. Int. J. Cancer 1988;42: 352–358.

    Article  PubMed  CAS  Google Scholar 

  49. Wils JA, Bleiberg H. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy? Acta Gastro-Enterol. Belgica 1987; XL: 114–120.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, University of Hamburg, FRG

    R. Klapdor

  2. Department of Nuclear Medicine, University of Hamburg, FRG

    R. Montz

Authors
  1. R. Klapdor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Montz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klapdor, R., Montz, R. Radioimmunodiagnosis of pancreatic cancer disease. Int J Pancreatol 9, 99–111 (1991). https://doi.org/10.1007/BF02925585

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02925585

Key Words

Search

Navigation